We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.9%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$113B
AUM Growth
+$3.29B
(+3%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
17.16%
Holding
4,363
New
403
Increased
1,677
Reduced
1,774
Closed
295
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$603M |
| 2 |
Entergy
ETR
|
+$403M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$296M |
| 5 |
CELG
Celgene Corp
CELG
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.67B |
| 2 |
AABA
Altaba Inc
AABA
|
+$373M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$232M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$229M |
| 5 |
IBM
IBM
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.95% |
| 2 | Healthcare | 10.9% |
| 3 | Financials | 9.6% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Industrials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
CALL
Patterson-UTI
PTEN
$3.54B
| $197K | ﹤0.01% |
+17,100
| New | +$220K |
|
|
HPR
3727
DELISTED
HighPoint Resources Corporation
HPR
| $197K | ﹤0.01% |
2,173
-184
| -8% | -$20.5K |
|
3728
Mitek Systems
MITK
$756M
| $196K | ﹤0.01% |
19,767
-1,160,493
| -98% | -$12.4M |
|
|
FPRX
3729
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $195K | ﹤0.01% |
32,362
+6,406
| +25% | +$61.2K |
|
|
AGEN
3730
Agenus
AGEN
$276M
| $194K | ﹤0.01% |
3,304
+75
| +2% | +$4.1K |
|
3731
Citizens
CIA
$248M
| $193K | ﹤0.01% |
26,429
-10,594
| -29% | -$72.6K |
|
3732
Caesarstone
CSTE
$69.5M
| $192K | ﹤0.01% |
12,777
-545
| -4% | -$8.15K |
|
3733
Geron
GERN
$898M
| $192K | ﹤0.01% |
136,498
+7,903
| +6% | +$13.1K |
|
3734
Intrepid Potash
IPI
$476M
| $192K | ﹤0.01% |
5,712
-711
| -11% | -$24.8K |
|
3735
Sonos
SONO
$2.09B
| $192K | ﹤0.01% |
+16,892
| New | +$186K |
|
|
TGH
3736
DELISTED
Textainer Group Holdings limited
TGH
| $192K | ﹤0.01% |
19,139
-1,201
| -6% | -$11.8K |
|
|
SRNE
3737
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $191K | ﹤0.01% |
71,530
-5,348
| -7% | -$19.2K |
|
|
BPY
3738
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $189K | ﹤0.01% |
10,016
-257,287
| -96% | -$5.13M |
|
|
BEDU
3739
DELISTED
Bright Scholar Education Holdings
BEDU
| $186K | ﹤0.01% |
5,135
-340
| -6% | -$14.4K |
|
|
IMGN
3740
DELISTED
Immunogen Inc
IMGN
| $186K | ﹤0.01% |
85,701
-42,093
| -33% | -$99.5K |
|
3741
TORM
TRMD
$3.05B
| $185K | ﹤0.01% |
22,886
+4,145
| +22% | +$36.7K |
|
|
MHN
3742
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $184K | ﹤0.01% |
14,000
| – | – |
|
3743
Ameresco
AMRC
$980M
| $183K | ﹤0.01% |
+12,450
| New | +$191K |
|
|
EEX
3744
DELISTED
Emerald Holding
EEX
| $183K | ﹤0.01% |
16,361
+3,892
| +31% | +$48.5K |
|
|
CPRX
3745
DELISTED
Catalyst Pharmaceutical
CPRX
| $182K | ﹤0.01% |
47,545
+26,181
| +123% | +$113K |
|
3746
Inovio Pharmaceuticals
INO
$85.6M
| $182K | ﹤0.01% |
5,176
+210
| +4% | +$8.34K |
|
|
NINE
3747
DELISTED
Nine Energy Service
NINE
| $178K | ﹤0.01% |
10,276
-14,093
| -58% | -$280K |
|
|
HUD
3748
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $178K | ﹤0.01% |
12,921
-66,676
| -84% | -$976K |
|
3749
Park Aerospace
PKE
$720M
| $177K | ﹤0.01% |
10,664
-7,672
| -42% | -$123K |
|
|
DVAX
3750
DELISTED
Dynavax Technologies
DVAX
| $176K | ﹤0.01% |
44,336
+3,688
| +9% | +$21.4K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2019 Portfolio in Review
As of Q2 2019, Credit Suisse held 4,363 positions worth $113B, up 3% from $110B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse's Q2 2019 filing shows 403 new, 1,677 increased, 1,774 reduced and 295 closed positions. Its largest new stake was Alcon: 10,270,934 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.67B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- Credit Suisse's largest Q2 2019 buy was Alcon: 10,270,934 shares worth $637M.
- Credit Suisse added most to Entergy in Q2 2019, an estimated $403M increase.
- Credit Suisse's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.67B.
- Credit Suisse fully exited iShares Core MSCI Total International Stock ETF in Q2 2019, selling an estimated $232M.
- Credit Suisse's ten largest holdings make up 17% of its $113B portfolio in Q2 2019.
- Credit Suisse opened 403 new positions and closed 295 in Q2 2019.
- Credit Suisse's portfolio value rose 3% quarter-over-quarter to $113B.
Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.